AMYPAD project reports on highlights in 2021
The collaboration within the AMYPAD consortium has been productive and efficient during the fifth year of the
AMYPAD
Uncertainty of MR-PET image registration is mainly driven by the quality of PET images
Accurate regional brain quantitative PET measurements, particularly when using partial volume correction, rely on robust
Quantifying longitudinal & regional changes in Aβ can improve the prediction of cognitive functioning
The value of quantitative longitudinal and regional amyloid beta (Aβ) measurements in predicting cognitive decline
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Neuronet convenes 7th meeting of its Scientific Coordination Board
On 21 October, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
AMYPAD holds its General Assembly Meeting
On 8 and 9 October, the “Amyloid imaging to Prevent Alzheimer’s disease” (AMYPAD) consortium held
Neuronet Working Groups emphasise the importance of effective collaboration to overcome obstacles linked to patient privacy and data sharing
As a coordination and support action, Neuronet has been designed to enhance the impact and
The Innovative Medicines Initiative’s impact on dementia – presentations online!
The Innovative Medicines Initiative (IMI) organised a series of online live sessions on its impact.
EPAD-AMYPAD Imaging Workshop
On 17 June, the Innovative Medicines Initiative (IMI) projects EPAD and AMYPAD organised a virtual
Communication representatives of neurodegeneration research projects exchange on best practices
On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to